[account_shop_links]
China: Clinical Development Profile
$2,960.00 – $5,920.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
ISR’s report explores how often various outsourcing models are used, sponsor satisfaction with models, the driving forces behind using each type of model, as well as which situations would be likely to cause a sponsor to deviate from their standard outsourcing design.
What you will learn:
- How population health status, regulations, clinical trial activity, and international and domestic company partnerships make China one of the top emerging global pharmaceutical markets
- Insights from domestic service provider organizations on conducting clinical trials in China
- Clinical trial operational metrics for China-only clinical studies
- Compiled lists and contact details for domestic and international service providers in China
How you can use this report:
- Understand how China compares to other countries on a variety of health condition scales so the reader can consider the areas in which China may be beneficial as a trail site
- Understand the legal, logistical, and regulatory details for conducting Chinese trials, and illustrate the benefits and drawbacks of conducting trials in China
Methodology:
ISR gathered content for this report via an exhaustive secondary research effort and from company profile questionnaires that were distributed to CROs profiled in this report.
